Generic Name and Formulations:
Dinoprostone 10mg; controlled-release vaginal insert w. retrieval system.
Indications for CERVIDIL:
Cervical ripening in patients at or near term when there is an indication for labor induction.
Fetal distress where delivery is not imminent. Unexplained vaginal bleeding. Presence or suspicion of cephalopelvic disproportion. Where oxytocics or prolonged uterine contractions are inappropriate, including previous cesarean section, major uterine surgery. Multipara with ≥6 previous term pregnancies. Concomitant oxytocics. Remove insert if uterine hyperstimulation, labor, sustained uterine contractions, or other fetal/maternal adverse reactions occur and prior to amniotomy.
For hospital use when appropriate obstetric care is present. Ruptured membranes. Non-vertex, non-singleton presentation. Previous uterine hypertony. Glaucoma. History of childhood asthma. Monitor uterine activity, fetal status, cervical dilatation/effacement. Pregnancy (Cat.C).
Potentiates oxytocics; delay administration of oxytocics at least 30 minutes after removal of insert.
Uterine hyperstimulation, fetal distress.
Psychiatry Advisor Articles
- Continuing Research, Emerging Treatments Hold Promise for Treating Anorexia Nervosa
- ACOG Update: Marijuana Use Discouraged During Pregnancy, Breastfeeding
- Asenapine Prevents Recurrence of Mood Events in Bipolar Disorder
- Depression Profiles in Patients With Type 1 Diabetes vs Type 2 Diabetes
- Purpose, Questions of Social Interaction Lead Physicians to Delay Retirement
- CBT, Acceptance Commitment Therapy Helpful for Those With Chronic Pain
- Suicidal Behavior, Thoughts Associated With Perfectionist Tendencies
- Depression Reduced by Social Belonging, Feelings of Inclusion
- Sleep Disturbance May Be Causal Factor in Psychotic Experiences
- Is Antidepressant Use in Pregnancy Tied to Psychiatric Disorders in Offspring?
- SSRI Use Associated With Increased Type 2 Diabetes Risk in Young Adults
- Improved Patient-Provider Communication Needed Following Urgent Care Visits
- Cardiovascular Risk Management May Slow Neurocognitive Decline in HIV
- Maintenance rTMS for Treatment-Resistant Depression
- New Study Compares Opioid Dependence Relapse Treatments